Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Roche and AbbVie's leukaemia combo smashes Phase 3 endpoint
Venclexta/Venclyxto (venetoclax) successfully met its primary endpoint in Phase 3 trials, providing prolonged, progression-free survival in chronic...
Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal Products for...
FDA locks down combo immunotherapy trials, Roche added to hold
Roche's Tecentriq has been added to the list of immunotherapy treatments placed on a partial hold by the FDA over safety concerns.
Teva completes sale of women’s health for $1.38 billion
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for $1.1 billion...
>> More Manufacturing and Production News Stories

Features

Standing together: Supercharging the clinical trial in Europe

The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating collaboration and...

>> More Features

Appointments

Scholar Rock prise Regulatory Affairs director away from Biogen

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins Scholar Rock...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches